<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Alcon Ag — News on 6ix</title>
    <link>https://6ix.com/company/alcon-ag</link>
    <description>Latest news and press releases for Alcon Ag on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 09 Apr 2026 04:01:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/alcon-ag" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68361a7478dffbe2df13ec71.webp</url>
      <title>Alcon Ag</title>
      <link>https://6ix.com/company/alcon-ag</link>
    </image>
    <item>
      <title>Mexican Gold Mining Corp. and Alcon Silver Corp. Announce Arrangement Agreement to Create a Diversified Precious Metals Exploration Company</title>
      <link>https://6ix.com/company/alcon-ag/news/mexican-gold-mining-corp-and-alcon-silver-corp-announce-arrangement-agreement-to-create-a-diversified-precious-metals-exploration-company-1</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/mexican-gold-mining-corp-and-alcon-silver-corp-announce-arrangement-agreement-to-create-a-diversified-precious-metals-exploration-company-1</guid>
      <pubDate>Thu, 09 Apr 2026 04:01:00 GMT</pubDate>
      <description>Vancouver, British Columbia--(Newsfile Corp. - April 9, 2026) - Mexican Gold Mining Corp. (TSXV: MEX) (&quot;Mexican Gold&quot; or the &quot;Purchaser&quot;) and Alcon Silver Corp. (&quot;Alcon&quot; or the &quot;Company&quot;) are pleased to announce that they have entered into an arrangement agreement (the &quot;Arrangement Agreement&quot;) dated April 8, 2026, pursuant to which Mexican Gold will acquire all of the issued and outstanding common shares of Alcon (the &quot;Company Shares&quot;) in exchange for newly issued common shares in the capital of</description>
    </item>
    <item>
      <title>Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada</title>
      <link>https://6ix.com/company/alcon-ag/news/systane-steps-up-to-the-plate-as-the-official-eye-drop-of-the-toronto-blue-jays-raising-awareness-of-dry-eye-in-canada</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/systane-steps-up-to-the-plate-as-the-official-eye-drop-of-the-toronto-blue-jays-raising-awareness-of-dry-eye-in-canada</guid>
      <pubDate>Tue, 07 Apr 2026 16:15:00 GMT</pubDate>
      <description>TORONTO, April 07, 2026--This season, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that Systane® has partnered with the Toronto Blue Jays as the official eye drop of the team. The partnership aims to help Canadians recognize the signs of dry eye and stay comfortable throughout the game.</description>
    </item>
    <item>
      <title>Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-launches-clareon-truplus-enhanced-design-monofocal-and-toric-iols-at-ascrs-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-launches-clareon-truplus-enhanced-design-monofocal-and-toric-iols-at-ascrs-2026</guid>
      <pubDate>Mon, 06 Apr 2026 12:03:00 GMT</pubDate>
      <description>FORT WORTH, Texas, April 06, 2026--Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026</description>
    </item>
    <item>
      <title>Alcon Publishes Agenda for 2026 Annual General Meeting</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-publishes-agenda-for-2026-annual-general-meeting</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-publishes-agenda-for-2026-annual-general-meeting</guid>
      <pubDate>Thu, 02 Apr 2026 20:30:00 GMT</pubDate>
      <description>GENEVA, April 02, 2026--Alcon Publishes Agenda for 2026 Annual General Meeting</description>
    </item>
    <item>
      <title>Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-and-lensar-inc-agree-to-terminate-merger-agreement-1</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-and-lensar-inc-agree-to-terminate-merger-agreement-1</guid>
      <pubDate>Mon, 16 Mar 2026 20:57:00 GMT</pubDate>
      <description>GENEVA, March 16, 2026--Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement</description>
    </item>
    <item>
      <title>Alcon Surpasses 175 Million IOLs Implanted Globally</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-surpasses-175-million-iols-implanted-globally</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-surpasses-175-million-iols-implanted-globally</guid>
      <pubDate>Mon, 02 Mar 2026 13:03:00 GMT</pubDate>
      <description>GENEVA, March 02, 2026--Alcon Surpasses 175 Million IOLs Implanted Globally</description>
    </item>
    <item>
      <title>LENSAR® Provides Update on Pending Acquisition by Alcon</title>
      <link>https://6ix.com/company/alcon-ag/news/lensarr-provides-update-on-pending-acquisition-by-alcon-1</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/lensarr-provides-update-on-pending-acquisition-by-alcon-1</guid>
      <pubDate>Wed, 25 Feb 2026 22:00:00 GMT</pubDate>
      <description>ORLANDO, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today provided an update on the status of its pending acquisition by Alcon Research, LLC (“Alcon”). The Company and Alcon continue to cooperate with the U.S. Federal Trade Commission (the “FTC”) staff in connection with its Request for Additional Information and Documentary Materia</description>
    </item>
    <item>
      <title>Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-delivers-strong-fourth-quarter-2025-topline-growth-as-new-product-launches-accelerate-sales</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-delivers-strong-fourth-quarter-2025-topline-growth-as-new-product-launches-accelerate-sales</guid>
      <pubDate>Tue, 24 Feb 2026 21:30:00 GMT</pubDate>
      <description>GENEVA, February 24, 2026--Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales</description>
    </item>
    <item>
      <title>Alcon Launches TOTAL30 Multifocal for Astigmatism, the World’s Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-launches-total30-multifocal-astigmatism-130300158</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-launches-total30-multifocal-astigmatism-130300158</guid>
      <pubDate>Tue, 17 Feb 2026 13:03:00 GMT</pubDate>
      <description>GENEVA, February 17, 2026--Alcon Launches TOTAL30 Multifocal for Astigmatism, the World’s Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology</description>
    </item>
    <item>
      <title>Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-debuts-groundbreaking-precision7-canada-140200792</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-debuts-groundbreaking-precision7-canada-140200792</guid>
      <pubDate>Mon, 02 Feb 2026 14:02:00 GMT</pubDate>
      <description>TORONTO, February 02, 2026--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the Canadian launch of PRECISION7® sphere and toric, the only one-week replacement contact lens with the revolutionary ACTIV-FLO® System2,5 that provides 16 hours of outstanding comfort and precise vision, even on day 7.1 The lenses will be commercially available in Canada in February.</description>
    </item>
    <item>
      <title>Alcon Completes $750 Million Share Repurchase Program</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-completes-dollar750-million-share-repurchase-program</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-completes-dollar750-million-share-repurchase-program</guid>
      <pubDate>Tue, 20 Jan 2026 21:30:00 GMT</pubDate>
      <description>GENEVA, January 20, 2026--Alcon Completes $750 Million Share Repurchase Program</description>
    </item>
    <item>
      <title>Alcon Terminates Agreement to Acquire STAAR Surgical</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-terminates-agreement-to-acquire-staar-surgical-1</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-terminates-agreement-to-acquire-staar-surgical-1</guid>
      <pubDate>Wed, 07 Jan 2026 01:00:00 GMT</pubDate>
      <description>GENEVA, January 07, 2026--Alcon Terminates Agreement to Acquire STAAR Surgical</description>
    </item>
    <item>
      <title>Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-to-present-at-2026-annual-jp-morgan-healthcare-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-to-present-at-2026-annual-jp-morgan-healthcare-conference</guid>
      <pubDate>Tue, 30 Dec 2025 21:30:00 GMT</pubDate>
      <description>GENEVA, December 30, 2025--Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.</description>
    </item>
    <item>
      <title>Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-exercises-right-to-require-staar-surgical-to-adjourn-its-special-meeting-of-stockholders</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-exercises-right-to-require-staar-surgical-to-adjourn-its-special-meeting-of-stockholders</guid>
      <pubDate>Fri, 19 Dec 2025 16:45:00 GMT</pubDate>
      <description>LAKE FOREST, Calif., December 19, 2025--STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to require STAAR to adjourn its Special Meeting of Stockholders in connection with the Alcon merger agreement (the &quot;Special Meeting&quot;). As a result, the Special Meeting, which was scheduled for December 19, 2025 at 8:30 a.m. Pacific Time, has been adjourned to Janu</description>
    </item>
    <item>
      <title>Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote &quot;FOR&quot; Alcon Merger</title>
      <link>https://6ix.com/company/alcon-ag/news/leading-independent-proxy-advisory-firm-iss-recommends-staar-stockholders-vote-for-alcon-merger</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/leading-independent-proxy-advisory-firm-iss-recommends-staar-stockholders-vote-for-alcon-merger</guid>
      <pubDate>Mon, 15 Dec 2025 23:35:00 GMT</pubDate>
      <description>LAKE FOREST, Calif., December 15, 2025--STAAR Surgical Company (NASDAQ: STAA) (&quot;STAAR&quot;), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that leading independent proxy advisory firm Institutional Shareholder Services (&quot;ISS&quot;) has issued a new report and revised its recommendation with respect to STAAR’s merger with Alcon. ISS is now recommending that all STAAR stockholders vote &quot;FOR&quot; STAAR’s amended merger agre</description>
    </item>
    <item>
      <title>Alcon Announces Amended Merger Agreement with STAAR Surgical</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-announces-amended-merger-agreement-with-staar-surgical</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-announces-amended-merger-agreement-with-staar-surgical</guid>
      <pubDate>Tue, 09 Dec 2025 13:30:00 GMT</pubDate>
      <description>GENEVA, December 09, 2025--Alcon Announces Amended Merger Agreement with STAAR Surgical</description>
    </item>
    <item>
      <title>STAAR Surgical Announces Expiration of Go-Shop Period</title>
      <link>https://6ix.com/company/alcon-ag/news/staar-surgical-announces-expiration-of-go-shop-period</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/staar-surgical-announces-expiration-of-go-shop-period</guid>
      <pubDate>Mon, 08 Dec 2025 13:00:00 GMT</pubDate>
      <description>LAKE FOREST, Calif., December 08, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the expiration of the previously announced go-shop period pursuant to STAAR’s amended merger agreement with Alcon Inc. (SIX/NYSE: ALC). The go-shop period expired at 11:59 p.m. Eastern Time on December 6, 2025. No proposals were received prior to the expiration.</description>
    </item>
    <item>
      <title>Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-delivers-solid-third-quarter-2025-results-with-accelerated-growth-in-equipment-and-ocular-health-unity-vcs-momentum-builds</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-delivers-solid-third-quarter-2025-results-with-accelerated-growth-in-equipment-and-ocular-health-unity-vcs-momentum-builds</guid>
      <pubDate>Tue, 11 Nov 2025 21:30:00 GMT</pubDate>
      <description>GENEVA, November 11, 2025--Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds</description>
    </item>
    <item>
      <title>STAAR Surgical Announces Amendments to Alcon Merger Agreement</title>
      <link>https://6ix.com/company/alcon-ag/news/staar-surgical-announces-amendments-to-alcon-merger-agreement</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/staar-surgical-announces-amendments-to-alcon-merger-agreement</guid>
      <pubDate>Fri, 07 Nov 2025 15:10:00 GMT</pubDate>
      <description>LAKE FOREST, Calif., November 07, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the Company has agreed with Alcon Inc. (SIX/NYSE: ALC) to amend their merger agreement to allow proactive solicitation by STAAR of third-party proposals to maximize value for all STAAR stockholders.</description>
    </item>
    <item>
      <title>Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders</title>
      <link>https://6ix.com/company/alcon-ag/news/alcon-releases-investor-discussion-materials-reinforcing-certain-value-of-merger-proposal-for-staar-stockholders</link>
      <guid isPermaLink="true">https://6ix.com/company/alcon-ag/news/alcon-releases-investor-discussion-materials-reinforcing-certain-value-of-merger-proposal-for-staar-stockholders</guid>
      <pubDate>Tue, 04 Nov 2025 06:00:00 GMT</pubDate>
      <description>GENEVA, November 04, 2025--Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders</description>
    </item>
  </channel>
</rss>